Neurobiology of photophobia
R Burstein, R Noseda, AB Fulton - Journal of Neuro …, 2019 - journals.lww.com
Background: Photophobia is commonly associated with migraine, meningitis, concussion,
and a variety of ocular diseases. Advances in our ability to trace multiple brain pathways …
and a variety of ocular diseases. Advances in our ability to trace multiple brain pathways …
Photophobia: when light hurts, a review
A Albilali, E Dilli - Current neurology and neuroscience reports, 2018 - Springer
Abstract Purpose of Review To provide an updated overview of Photophobia with a
particular focus on photophobia related to migraine. Recent Findings Melanopsin-containing …
particular focus on photophobia related to migraine. Recent Findings Melanopsin-containing …
Behavioral study of a rat model of migraine induced by CGRP
G Yao, Q Huang, M Wang, CL Yang, CF Liu, TM Yu - Neuroscience Letters, 2017 - Elsevier
Migraine is a debilitating disorder characterized by recurrent headache arising from
neurovascular dysfunction. Despite recent progress in migraine research, the exact …
neurovascular dysfunction. Despite recent progress in migraine research, the exact …
CGRP and its receptors provide new insights into migraine pathophysiology
Over the past 300 years, the migraine field has been dominated by two main theories—the
vascular theory and the central neuronal theory. The success of vasoconstrictors such as …
vascular theory and the central neuronal theory. The success of vasoconstrictors such as …
Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide
E Fabbretti, M D'Arco, A Fabbro… - Journal of …, 2006 - Soc Neuroscience
Recent evidence indicates a key role for the neuropeptide calcitonin gene-related peptide
(CGRP) in migraine pain, as demonstrated by the strong analgesic action of CGRP receptor …
(CGRP) in migraine pain, as demonstrated by the strong analgesic action of CGRP receptor …
Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies
S Miller, H Liu, K Warfvinge, L Shi, M Dovlatyan, C Xu… - Neuroscience, 2016 - Elsevier
Calcitonin gene-related peptide (CGRP) is a potent vasodilator and a neuromodulator
implicated in the pathophysiology of migraine. It binds to the extracellular domains of …
implicated in the pathophysiology of migraine. It binds to the extracellular domains of …
Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine
PL Durham, CV Vause - CNS drugs, 2010 - Springer
Based on preclinical and clinical studies, the neuropeptide calcitonin gene-related peptide
(CGRP) is proposed to play a central role in the underlying pathology of migraine. CGRP …
(CGRP) is proposed to play a central role in the underlying pathology of migraine. CGRP …
Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: A detailed study using in situ hybridization, immunofluorescence …
S Eftekhari, RC Gaspar, R Roberts… - Journal of …, 2016 - Wiley Online Library
Functional imaging studies have revealed that certain brainstem areas are activated during
migraine attacks. The neuropeptide calcitonin gene–related peptide (CGRP) is associated …
migraine attacks. The neuropeptide calcitonin gene–related peptide (CGRP) is associated …
[HTML][HTML] Sex differences in the expression of calcitonin gene-related peptide receptor components in the spinal trigeminal nucleus
Y Ji, A Rizk, P Voulalas, H Aljohani, S Akerman… - Neurobiology of Pain, 2019 - Elsevier
Background and purpose Calcitonin gene-related peptide (CGRP) plays an important role in
migraine pathophysiology. CGRP acts primarily by activating a receptor composed of 3 …
migraine pathophysiology. CGRP acts primarily by activating a receptor composed of 3 …
No central action of CGRP antagonising drugs in the GTN mouse model of migraine
Introduction Clinically, calcitonin gene-related peptide antagonising drugs are recognized
as effective in migraine treatment, but their site of action is debated. Only a small fraction of …
as effective in migraine treatment, but their site of action is debated. Only a small fraction of …